OptimizeRx market cap OPRX
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $177.2M
- Highest close in our data
- $1.7B
- Oct 2021
OptimizeRx is worth $177.2M at the close on Nov 2, 2026, at $9.41 a share.
That is down 39% over the last year and down 89% over five years.
Its highest close in our data was $1.7B in Oct 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $177.2M | $92.7M | $245.3M | −24% |
| 2025 | $232.6M | $84.4M | $402.5M | +148% |
| 2024 | $93.8M | $70.6M | $293.5M | −64% |
| 2023 | $259.8M | $121.3M | $325.7M | −10% |
| 2022 | $288.2M | $248.2M | $946.8M | −74% |
| 2021 | $1.1B | $573.5M | $1.7B | +134% |
| 2020 | $470.8M | $95.7M | $477.1M | +230% |
| 2019 | $142.7M | $128.1M | $232M | +21% |
| 2018 | $118.2M | $37.5M | $209.5M | +157% |
| 2017 | $46M | $20.8M | $46M | +91% |
| 2016 | $24M | $23.4M | $35.3M | −32% |
| 2015 | $35.4M | $19.5M | $38.3M | +45% |
| 2014 | $24.3M | $20.1M | $41.1M | −0% |
| 2013 | $24.4M | $14.3M | $28.2M | +71% |
| 2012 | $14.2M | $9.9M | $26.3M | +13% |
| 2011 | $12.6M | $12.6M | $19.3M | n/a |
Against its peers
Companies in Financial - Credit Services nearest OptimizeRx's size, closest first, today.
| Company | Market cap |
|---|---|
| OPRXOptimizeRx | $177.2M |
| DHXDHI | $207.6M |
| CPSSConsumer Portfolio Services | $218.7M |
| SNFCASecurity National Financial | $254.1M |
| POWWOutdoor | $279.6M |
| IMXIInternational Money Express | $287.6M |
| IRHOIron Horse Acquisition II | $296M |
| LSAKLesaka Technologies | $346.7M |
| RMRegional Management | $350.8M |
| TREELendingTree | $380.2M |
| MACIMelar Acquisition Corp. I/Cayman | $72.6M |
| Peer median | $283.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on OptimizeRx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.